Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 15;201(12):1575-1578.
doi: 10.1164/rccm.201912-2514LE.

BMP9/10 in Pulmonary Vascular Complications of Liver Disease

Elizabeth R Rochon  1 , Michael J Krowka  2 , Sonja Bartolome  3 , Gustavo A Heresi  4 , Todd Bull  5 , Kari Roberts  6 , Anna Hemnes  7 , Kimberly A Forde  8 , Karen L Krok  9 , Mamta Patel  8 , Grace Lin  2 , Megan McNeil  9   10 , Nadine Al-Naamani  8 , Beth L Roman  11 , Paul B Yu  9   12 , Michael B Fallon  12 , Mark T Gladwin  1 , Steven M Kawut  8
Affiliations

BMP9/10 in Pulmonary Vascular Complications of Liver Disease

Elizabeth R Rochon et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
BMP9 (bone morphogenetic protein 9) and BMP10 levels for hepatopulmonary syndrome (HPS) (n = 80), cirrhotic control subjects (n = 121), portopulmonary hypertension (POPH) (n = 35), and cirrhotic control subjects (n = 186). Lines represent medians, boxes represent interquartile ranges, and whiskers show adjacent values.
See this image and copyright information in PMC

References

    1. Fallon MB, Krowka MJ, Brown RS, Trotter JF, Zacks S, Roberts KE, et al. Pulmonary Vascular Complications of Liver Disease Study Group. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology. 2008;135:1168–1175. - PMC - PubMed
    1. Colle IO, Moreau R, Godinho E, Belghiti J, Ettori F, Cohen-Solal A, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology. 2003;37:401–409. - PubMed
    1. Tillet E, Ouarné M, Desroches-Castan A, Mallet C, Subileau M, Didier R, et al. A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma. J Biol Chem. 2018;293:10963–10974. - PMC - PubMed
    1. Bidart M, Ricard N, Levet S, Samson M, Mallet C, David L, et al. BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain. Cell Mol Life Sci. 2012;69:313–324. - PMC - PubMed
    1. David L, Mallet C, Keramidas M, Lamandé N, Gasc JM, Dupuis-Girod S, et al. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res. 2008;102:914–922. - PMC - PubMed

Publication types

MeSH terms

Substances